Private Equity


Healthcare is a dynamic sector undergoing continuous change. 

Fundamental growth drivers include an ageing and more active population; increasing access to healthcare globally; rapid advancements in biologics and personalised medicine (including cell and gene therapies), minimally invasive medical devices, and "omics" research that includes genomics, proteomics, epigenomics among others; increasing consumer engagement in personal healthcare decisions; and a growing focus on value-based care delivery.

We seek to partner with leading businesses to improve patient outcomes by facilitating enhanced research, increasing speed to market, and managing cost through the value chain, from innovation to development to commercialisation. 

We invest in growth and support our portfolio through organic and acquisition-led development, helping our partners strategically transform their organisation during our ownership to create better outcomes and generate significant value.

Within the Healthcare sector, we focus on the following areas:

  • Outsourced medical device manufacturing & services
  • Outsourced pharmaceutical manufacturing & services 
  • Bioprocessing supply chain
  • Life science tools and diagnostics
  • Wellness & consumer health products


Track record

Track record: Havea

3i’s Rémi Carnimolla and Havea’s Nicolas Brodetsky discuss how the partnership helped Havea make five acquisitions in five years and double the size of the business.

Back to top